HCL Technologies Ltd.

BSE: 532281 | NSE: HCLTECH
Large Cap | IT - Software
1721.15
-9.25 (-0.53%)
< Home < Back

HCL Technologies acquires C3i Solutions

Date: 06-04-2018

HCL Technologies has acquired C3i Solutions, a leader in multi-channel customer engagement services for the life sciences and consumer packaged goods (CPG) industries, from Merck & Co., Inc., Kenilworth, New Jersey, USA (known as MSD outside of the United States and Canada). With this acquisition, the company will complement its broad-based IT and business services capability with the additional depth that C3i has in the life sciences and CPG verticals.

C3i’s expertise in the clinical, pharmacovigilance, and pharma sales support domains and strong partnership with industry leading products in these respective areas will enable HCL’s life sciences customers to become more patient-centric and offer services to IT and business stakeholders to improve healthcare outcomes.

HCL Technologies is a leading global IT services company that helps global enterprises re–imagine and transform their businesses through digital technology transformation.